Table 3 Clinical and imaging characteristics of patients (n = 75) with T2 and T3 in final pathology
T2 (27, 36.0%) | T3 (48, 64.0%) | p | |
|---|---|---|---|
Age (years), median (range) | 69 (58–82) | 68 (55–84) | 0.868 |
Initial PSA (ng/dL), median (range) | 9.87 (4.15–60.17) | 15.06 (5.42–120) | 0.016 |
Percentage of positive core at TB (%), median (range) | 28.6 (7.1–81.2) | 41.7 (7.1–100) | 0.031 |
ISUP Gleason score at TB, n (%) | 0.032 | ||
1 | 8 (29.6) | 5 (10.4) | |
2 | 8 (29.6) | 6 (12.5) | |
3 | 3 (11.1) | 6 (12.5) | |
4 | 6 (22.2) | 21 (43.8) | |
5 | 2 (7.4) | 10 (20.8) | |
mpMRI + PET/CT, n (%) | |||
scale | 0.013 | ||
2 | 1 (3.7) | 3 (6.3) | |
3 | 9 (33.3) | 6 (12.5) | |
4 | 12 (44.4) | 7 (14.6) | |
5 | 1 (3.7) | 6 (12.5) | |
6 | 3 (11.1) | 12 (25.0) | |
7 | 1 (3.7) | 4 (8.3) | |
8 | 0 (0) | 3 (6.25) | |
9 | 0 (0) | 5 (10.4) | |
10 | 0 (0) | 2 (4.16) | |
Diagnosis | < 0.001 | ||
Positive | 5 | 32 | |
Negative | 22 | 16 | |